atropine

Drug ingredientActive Shortage

CAS 51-55-8

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

US productionNot reported

Import value, 2024$171M

Top sourceSwitzerland 40%

This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293979 · basket

These shares come from HS customs code 293979, which covers 60 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

CH 40%SwitzerlandCN 18%ChinaIT 14%ItalyDE 13%GermanyIN 10%India

Australia
Poland
Belgium
Taiwan
Canada
Japan
Spain
Mexico
New Zealand
Slovenia
Israel

10 FDA-registered drug labelers

Boehringer Ingelheim Pharma GmbH and Co. KG

Deseret Biologicals, Inc.

Green Earth Health Inc.

Meridian Medical Technologies LLC

MINSHENG GROUP SHAOXING PHARMACEUTICAL CO,. LTD.

Professional Complementary Health Formulas

Rafa Laboratories, Ltd.

Rolabo Outsourcing, S.L.

Siegfried Grafton, Inc.

Vitality Works, Inc.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 5 drug and cosmetic product listings (FDA).

•Mdfarma COLD and FLU Relief
•Atropen Auto-Injector
•Rage
•NRV-Systemic
•Low Back Pain Drops 2041

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

Active Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

Current shortage
Atropine Sulfate Injection
Shortage listed since January 1, 2012
Manufacturer reports: 2 unavailable, 3 available

See all current drug shortages

Chemical Identity

CAS51-55-8

PubChem CID174174

DTXSIDDTXSID4020113

FormulaC17H23NO3

Mol. Weight289.4 g/mol

SMILESCN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3

Data Sources

PubChem · compound 174174Retrieved 2026-04-07
EPA TSCA InventoryRetrieved 2026-04-24
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

atropine (CAS 51-55-8) https://chemicalindependence.com/chemical/51-55-8/ PubChem: 174174. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/174174 EPA TSCA Inventory: CAS 51-55-8. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 51-55-8. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293979 for CAS 51-55-8. Reporting year: 2024. https://usatrade.census.gov/